DUBLIN, Feb 16, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Halal Pharmaceuticals Market Analysis & Trends - Product Type, Drug Classes, Source Material - Forecast to 2025" report to their offering.
Some of the prominent trends that the market is witnessing include growing need for certified medicines is propelling regulatory convergence, increasing awareness on satisfying religious needs, recent technological developments of halal pharmaceuticals, and growth opportunities/investment opportunities.
Based on Product type the market is categorized into capsules, tablets, syrups, and other product types. As per Source material the market is segmented into synthetic and semi-synthetic sources, animals, recombinant DNA, and plant and plant derivatives. By Drug Class the market is segregated into endocrine drugs, allergies, respiratory drugs, pain medications, cardiovascular drugs, and other drug classes.
This industry report analyzes the global markets for Halal Pharmaceuticals across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Scope of the Report
- Endocrine Drugs
- Respiratory Drugs
- Pain Medications
- Cardiovascular Drugs
- Recombinant DNA
- Plant & derivatives
- Chemical Company of Malaysia Berhad
- EMBIL Pharmaceutical Co., Ltd
- Nutramedica Incorporated
- Pharmaniaga Bhd
- Simpor Pharma Sdn Bhd
For more information about this report visit http://www.researchandmarkets.com/research/37fp3b/global_halal
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-halal-pharmaceuticals--capsules-tablets--syrups-market-analysis--trends-2016---product-type-drug-classes-source-material-forecast-to-2025---research-and-markets-300408628.html
SOURCE Research and Markets